BioLingus (Cayman) Limited (SUBL): Biotech Firm Targets Neurodegenerative Diseases with Sublingual Delivery IPO 2024
BioLingus (Cayman) Limited (SUBL): BioLingus (Cayman) Limited (SUBL), a Swiss biotechnology company, is preparing for its IPO on February 23rd, 2024. The firm, founded in 2018, is focused on finding novel treatments for neurodegenerative illnesses, … Read more